BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34123858)

  • 1. Rearrangements of Blood and Tissue Fatty Acid Profile in Colorectal Cancer - Molecular Mechanism and Diagnostic Potential.
    Mika A; Duzowska K; Halinski LP; Pakiet A; Czumaj A; Rostkowska O; Dobrzycka M; Kobiela J; Sledzinski T
    Front Oncol; 2021; 11():689701. PubMed ID: 34123858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyper-Elongation in Colorectal Cancer Tissue - Cerotic Acid is a Potential Novel Serum Metabolic Marker of Colorectal Malignancies.
    Mika A; Kobiela J; Czumaj A; Chmielewski M; Stepnowski P; Sledzinski T
    Cell Physiol Biochem; 2017; 41(2):722-730. PubMed ID: 28214830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UHPLC-HRMS-based serum lipisdomics reveals novel biomarkers to assist in the discrimination between colorectal adenoma and cancer.
    Chen H; Zhang J; Zhou H; Zhu Y; Liang Y; Zhu P; Zhang Q
    Front Oncol; 2022; 12():934145. PubMed ID: 35965551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferential uptake of polyunsaturated fatty acids by colorectal cancer cells.
    Mika A; Kobiela J; Pakiet A; Czumaj A; Sokołowska E; Makarewicz W; Chmielewski M; Stepnowski P; Marino-Gammazza A; Sledzinski T
    Sci Rep; 2020 Feb; 10(1):1954. PubMed ID: 32029824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A circulating extracellular vesicles-based novel screening tool for colorectal cancer revealed by shotgun and data-independent acquisition mass spectrometry.
    Zheng X; Xu K; Zhou B; Chen T; Huang Y; Li Q; Wen F; Ge W; Wang J; Yu S; Sun L; Zhu L; Liu W; Gao H; Yue L; Cai X; Zhang Q; Ruan G; Zhu T; Wu Z; Zhu Y; Shao Y; Guo T; Zheng S
    J Extracell Vesicles; 2020; 9(1):1750202. PubMed ID: 32363013
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
    Chan EC; Koh PK; Mal M; Cheah PY; Eu KW; Backshall A; Cavill R; Nicholson JK; Keun HC
    J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered plasma levels of decanoic acid in colorectal cancer as a new diagnostic biomarker.
    Crotti S; Agnoletto E; Cancemi G; Di Marco V; Traldi P; Pucciarelli S; Nitti D; Agostini M
    Anal Bioanal Chem; 2016 Sep; 408(23):6321-8. PubMed ID: 27379390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LC-MS-based lipid profile in colorectal cancer patients: TAGs are the main disturbed lipid markers of colorectal cancer progression.
    Liu T; Peng F; Yu J; Tan Z; Rao T; Chen Y; Wang Y; Liu Z; Zhou H; Peng J
    Anal Bioanal Chem; 2019 Aug; 411(20):5079-5088. PubMed ID: 31201454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STUDY OF LIPID BIOMARKERS OF PATIENTS WITH POLYPS AND COLORECTAL CÂNCER.
    Serafim PVP; Figueiredo AG; Felipe AV; Turco EGL; Silva IDCGD; Forones NM
    Arq Gastroenterol; 2019; 56(4):399-404. PubMed ID: 31800736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered Serum Annexin A2 Might Be a New Potential Diagnostic Biomarker in Human Colorectal Cancer.
    Hu D; Shen B; Yu M; Zha X; Zhou Y; Chen F; Ren J; Zhang L
    Ann Clin Lab Sci; 2020 Nov; 50(6):726-733. PubMed ID: 33334786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary habits affect fatty acid composition of visceral adipose tissue in subjects with colorectal cancer or obesity.
    Scazzocchio B; Varì R; Silenzi A; Giammarioli S; Masotti A; Baldassarre A; Santangelo C; D'Archivio M; Giovannini C; Del Cornò M; Conti L; Gessani S; Masella R
    Eur J Nutr; 2020 Jun; 59(4):1463-1472. PubMed ID: 31119400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomics Analysis in Serum from Patients with Colorectal Polyp and Colorectal Cancer by
    Gu J; Xiao Y; Shu D; Liang X; Hu X; Xie Y; Lin D; Li H
    Dis Markers; 2019; 2019():3491852. PubMed ID: 31089393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool.
    Brown DG; Rao S; Weir TL; O'Malia J; Bazan M; Brown RJ; Ryan EP
    Cancer Metab; 2016; 4():11. PubMed ID: 27275383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal Fatty Acid Profiling as a Potential New Screening Biomarker in Patients with Colorectal Cancer.
    Song EM; Byeon JS; Lee SM; Yoo HJ; Kim SJ; Lee SH; Chang K; Hwang SW; Yang DH; Jeong JY
    Dig Dis Sci; 2018 May; 63(5):1229-1236. PubMed ID: 29516324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
    Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M
    Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of differential metabolic characteristics between tumor and normal tissue from colorectal cancer patients by gas chromatography-mass spectrometry.
    Ning W; Li H; Meng F; Cheng J; Song X; Zhang G; Wang W; Wu S; Fang J; Ma K; Yang J; Pei D; Dong F
    Biomed Chromatogr; 2017 Nov; 31(11):. PubMed ID: 28475217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of serum proteins as prognostic and predictive markers of colorectal cancer using surface enhanced laser desorption ionization-time of flight mass spectrometry.
    Helgason HH; Engwegen JY; Zapatka M; Vincent A; Cats A; Boot H; Beijnen JH; Schellens JH
    Oncol Rep; 2010 Jul; 24(1):57-64. PubMed ID: 20514444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased Triacylglycerol Content and Elevated Contents of Cell Membrane Lipids in Colorectal Cancer Tissue: A Lipidomic Study.
    Mika A; Pakiet A; Czumaj A; Kaczynski Z; Liakh I; Kobiela J; Perdyan A; Adrych K; Makarewicz W; Sledzinski T
    J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32290558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterizing metabolic changes in human colorectal cancer.
    Williams MD; Zhang X; Park JJ; Siems WF; Gang DR; Resar LM; Reeves R; Hill HH
    Anal Bioanal Chem; 2015 Jun; 407(16):4581-95. PubMed ID: 25943258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free Fatty Acids Signature in Human Intestinal Disorders: Significant Association between Butyric Acid and Celiac Disease.
    Baldi S; Menicatti M; Nannini G; Niccolai E; Russo E; Ricci F; Pallecchi M; Romano F; Pedone M; Poli G; Renzi D; Taddei A; Calabrò AS; Stingo FC; Bartolucci G; Amedei A
    Nutrients; 2021 Feb; 13(3):. PubMed ID: 33652681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.